The Foreign Ministry of the Government of India has cleared export of Paracetamol API, worth over US $250,000 to T&T according to press release from the High Commission of India in Port-of-Spain.
In a report on Friday, the Indian newspaper, the Hindu said that as a common fever medication, Paracetamol is the most sought after and widely used drug globally ever since the COVID-19 outbreak.
The Indian High Commission stated that T&T is among 63 countries, for which the export of the medicine has been approved. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways.
“This decision has been taken on a humanitarian grounds to ensure the supply of medicine which is widely used, including in cases with COVID-19. It may be noted that this is part of India’s efforts to contribute to the global efforts to combat the COVID-19 pandemic. It is also a symbol of our solidarity towards all the countries who require this medicine during the hour of need. A total of 1667.25 kg of the medicine with FOB value of US$256500 would be supplied by Milan Laboratories Pvt Ltd of India to T&T.”
The Indian High Commission also said that the Indian government has also approved the supply of the anti-malarial drug hydroxychloroquine, either as commercial sales or as grants, to 55 countries as part of the efforts to fight the global COVID-19 pandemic.
It has been reported in international news that U.S. President Trump has given backing to this drug as a “game changer” to deal with COVID-19 effects.
“The HCQ stands for Hydroxychloroquine, a medicine used to prevent and treat Malaria. As of now there are no specific anti-viral medications against Covid-19. In pre-clinical laboratory studies, HCQ has been found effective against coronavirus. So HCQ is being recommended for treatment under special circumstances and for protection of high-risk individuals.”
The High Commission also said that India leads in production and export of HCQ with 70 per cent of annual global production of its API in the country.
“India has come to be recognised as a reliable global supplier of medicines during this humanitarian crisis and it has reached out to many countries including T&T with delivery of essential medical supplies,” the press release said.